Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Hiv-1 envelope glycosylation and the signal peptide
Gregory S. Lambert
, Chitra Upadhyay
Graduate School of Biomedical Sciences
Icahn School of Medicine at Mount Sinai
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hiv-1 envelope glycosylation and the signal peptide'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Signal Peptide
100%
(I)-envelope
100%
Glycosylation
100%
HIV Vaccine
66%
Immunogen
66%
N-linked Glycans
66%
Vaccine Design
66%
Epitope
33%
Virion
33%
RV144
33%
Vaccine Trial
33%
Protective Effect
33%
HIV-1 Envelope
33%
HIV Knowledge
33%
Antibody Response
33%
Humoral Immune Response
33%
Trimeric
33%
Viral Proteins
33%
Difficult Targets
33%
Broadly Neutralizing Antibodies
33%
HIV-1 Infection
33%
Glyco
33%
Envelope Protein
33%
Envelope Trimer
33%
Envelope Signal
33%
HIV-1 Vaccine Design
33%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Glycosylation
100%
Peptides
100%
Glycan
28%
Virion
14%
Epitope
14%
Antibody Response
14%
Neutralizing Antibody
14%
Humoral Immunity
14%
Viral Protein
14%
Conformation
14%
RV 144
14%
Infection
14%
Biochemistry, Genetics and Molecular Biology
Glycosylation
100%
Human Immunodeficiency Virus 1
100%
Signal Peptide
100%
Polysaccharide
28%
Humoral Immunity
14%
Antibody Response
14%
Conformation
14%
Viral Protein
14%
Neutralizing Antibody
14%
Virion
14%